Francisco A. Bustamante, MBA, currently serves as President at ARx, LLC, where the focus is on innovative drug delivery systems, specifically drug-loaded dissolvable films and transdermal patches. Prior to this role, Francisco held the position of General Manager and Site Lead at Catalent Pharma Solutions, overseeing particle size engineering technologies. Previous experience includes serving as President at Lifeline Cell Technology, General Manager and VP of Operations at MESO SCALE DIAGNOSTICS, and Senior Manager roles at both QIAGEN and Lonza, specializing in production planning and supply chain management. Francisco began a career in manufacturing and production planning as Manager at Clonetics. Educational qualifications include a Bachelor of Arts in Biology from the University of San Diego and an MBA from Frostburg State University.
Previous companies
This person is not in any teams
This person is not in any offices
ARx, LLC
As a leading industry expert of drug-loaded dissolvable film and transdermal patch delivery systems, ARx, LLC is an innovative formulation development and manufacturing partner for novel drug products. ARx’s work expands dosage form possibilities for new or existing drug products by enhancing bioavailability and increasing patient compliance. The result is enriched patient well-being through robust drug delivery systems. ARx focuses primarily on transdermal and transmucosal routes of administration to leverage our proven expertise in Quality by Design (QbD)-based controls, formulation, analytical testing, clinical and commercial batch production. Our drug delivery systems and expertise include: - oral thin films - buccal, sublingual and mucosal thin films - transdermal and topical patches